SERA PROGNOSTICS, INC.
Develops predictive blood tests to assess preterm birth risk and improve pregnancy outcomes.
SERA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US81749D1072
- LEI:
- Country:
- United States of America
- Address:
- 2749 E. PARLEYS WAY, 84109 SALT LAKE CITY
- Website:
- https://www.sera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sera Prognostics, Inc., also known as The Pregnancy Company®, is a women's health diagnostics company focused on improving maternal and neonatal health through precision pregnancy care. The company utilizes proteomics and bioinformatics to develop and commercialize predictive biomarker tests. Its flagship product, the PreTRM® Test, is a blood-based test that predicts an individual's risk of spontaneous preterm delivery. Sera also offers the LikeMine™ platform, which provides data-driven pregnancy insights for mothers. By delivering pivotal information to physicians, payers, and patients, Sera aims to improve health outcomes and economics in prenatal care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SERA PROGNOSTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SERA PROGNOSTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SERA PROGNOSTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
